Wall Street Analysts Believe BioMarin (BMRN) Could Rally 37%: Here's is How to TradeZacks Investment Research • 11/01/21
SHAREHOLDER ALERT: Robbins LLP Announces that BioMarin Pharmaceutical Inc. (BMRN) is Being Sued for Misleading ShareholdersBusiness Wire • 11/01/21
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of APPH, BMRN and AMRNAccesswire • 10/31/21
Rosen, a Leading and Longstanding Firm, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BMRNNewsfile Corp • 10/30/21
ALERT: BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – BMRNBusiness Wire • 10/30/21
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NNOX, BMRN and RECAFAccesswire • 10/29/21
IMPORTANT REMINDER: BIOMARIN PHARMACEUTICAL INC. (BMRN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.Newsfile Corp • 10/29/21
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAM, BMRN and AMRNAccesswire • 10/29/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 10/28/21
BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21
BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the FirmBusiness Wire • 10/28/21
Lawsuits Filed Against SAM, BMRN and RECAF - Jakubowitz Law Pursues Shareholders ClaimsAccesswire • 10/27/21
SHAREHOLDER ALERT: INNV HEPS BMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesAccesswire • 10/27/21
BMRN DEADLINE: BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 10/27/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 10/26/21
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BMRNPRNewsWire • 10/26/21
CLASS ACTION UPDATE for HYRE, WDH and BMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersAccesswire • 10/26/21
BMRN ALERT: BioMarin Pharmaceutical Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 10/26/21
BMRN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BioMarin Pharmaceutical Inc. Investors of Class Action and Lead Plaintiff Deadline: December 21, 2021PRNewsWire • 10/26/21
BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceutical Inc.PRNewsWire • 10/25/21
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BMRNBusiness Wire • 10/25/21
